<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Enterovirus and parechovirus infections: Epidemiology and pathogenesis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Enterovirus and parechovirus infections: Epidemiology and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Enterovirus and parechovirus infections: Epidemiology and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Modlin, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Angela M Caliendo, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 14, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The human enteroviruses and parechoviruses are ubiquitous viruses that are transmitted from person to person via direct and indirect routes. Polioviruses, the prototypic enteroviruses, are the cause of paralytic poliomyelitis, a disease that has been highly controlled in the United States and other high-income countries and is targeted for global eradication. </p><p>The non-polio enteroviruses and parechoviruses are responsible for a wide spectrum of diseases in persons of all ages, although infection and illness occur most commonly in infants and young children. Epidemic hand-foot-mouth disease caused by enterovirus A71 has become an important global public health threat, particularly in the Asia-Pacific region, where vaccines are now available [<a href="#rid1">1</a>]. Acute flaccid myelitis (AFM), which has many epidemiologic and clinical characteristics that overlap with poliomyelitis, has caused periodic outbreaks in many countries since 2014 [<a href="#rid2">2</a>].</p><p>The epidemiology and pathogenesis of non-polio enterovirus and parechovirus infections are reviewed here. The clinical manifestations, diagnosis, management, and prevention of these infections are discussed in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention"</a> and  <a class="medical medical_review" href="/z/d/html/2695.html" rel="external">"Poliovirus vaccination"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>The enteroviruses and parechoviruses (and hepatitis A virus) are distinct genera within the Picornavirus family [<a href="#rid3">3</a>]. Enterovirus serotypes are distinguished from one another by neutralization with specific antisera. Originally, all enterovirus serotypes were assigned to one of four traditional sub-genera based on host range and pathogenic potential [<a href="#rid4">4</a>]. Of 69 serotypes once identified in these sub-genera, 64 remain after exclusion of redundant serotypes and reclassification of others [<a href="#rid5">5</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Polioviruses (serotypes 1 to 3)</p><p class="bulletIndent1"><span class="glyph">●</span>Group A coxsackieviruses (serotypes 1 to 22, 24)</p><p class="bulletIndent1"><span class="glyph">●</span>Group B coxsackieviruses (serotypes 1 to 6)</p><p class="bulletIndent1"><span class="glyph">●</span>Echoviruses (serotypes 1 to 9, 11 to 21, 24 to 27, 29 to 33)</p><p></p><p>Enteroviruses are now divided into four species, designated A through D, based on homology within the ribonucleic acid (RNA) region encoding the VP1 capsid protein [<a href="#rid6">6</a>]. Serotypes added since 1970 are simply named “enterovirus” with a species designation (eg, enterovirus D68). Multiple new enteroviruses have been identified and characterized by molecular methods, bringing the number of known serotypes to more than 100.</p><p>Isolates of the same serotype characteristically diverge in the VP1 region by less than 25 percent and less than 12 percent, respectively, within corresponding nucleotide and amino acid sequences [<a href="#rid6">6</a>]. </p><p>The parechoviruses share many biological, clinical, and epidemiologic characteristics with the enteroviruses, but differ sufficiently in genomic sequence to be classified as a separate genus [<a href="#rid7">7</a>]. The prototypic parechovirus serotypes 1 and 2 were originally designated echovirus 22 and 23, respectively. Four species (parechovirus A to D) and 14 parechovirus serotypes are now recognized [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H3"><span class="h1">VIROLOGY</span><span class="headingEndMark"> — </span>Enteroviruses and parechoviruses are small (approximately 27 nm), nonenveloped virions consisting of an icosahedral capsid composed of 60 subunits, each formed from four proteins (VP1 to VP4), that enclose a linear, single-strand, positive-sense RNA genome of about 7.5 kB. The translation product is a single polyprotein that is cleaved by viral coded proteases into the structural proteins (VP1 to VP4), an RNA polymerase, proteases, and other nonstructural proteins [<a href="#rid8">8</a>]. Enteroviruses are relatively acid resistant, maintaining infectivity over a wide pH range. They are resistant to ether and alcohol but inactivated at temperatures above 50°C, although molar <a class="drug drug_general" data-topicid="10122" href="/z/d/drug information/10122.html" rel="external">magnesium chloride</a> reduces lability at higher temperatures.</p><p class="headingAnchor" id="H4"><span class="h2">Intracellular replication</span><span class="headingEndMark"> — </span>Infection is initiated by attachment to specific cell membrane receptors that determine host cell susceptibility  (<a class="graphic graphic_table graphicRef50791" href="/z/d/graphic/50791.html" rel="external">table 1</a>). More than one receptor has been identified for some serotypes (eg, group B coxsackieviruses 1, 3, and 5 and enterovirus 71). Penetration and uncoating of the virion with release of RNA into the cell cytoplasm occurs within minutes, and synthesis of negative strand RNA begins within 30 minutes in vitro. The progeny positive-strand RNA serves as message for translation and is also encapsulated into newly formed virions. By 6 to 12 hours, complete virions are visible by electron microscopy. Each infected cell yields approximately 10<sup>4</sup> to 10<sup>5</sup> virions, although only 0.1 to 10 percent are infectious.</p><p class="headingAnchor" id="H5"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H473596835"><span class="h2">Seasonal and demographic distribution</span><span class="headingEndMark"> — </span>Enterovirus and parechovirus infection occurs throughout the year, with persons living in temperate climates experiencing higher rates of infection in summer and fall [<a href="#rid9">9</a>]. While enterovirus infections occur in all age groups, infants less than one year of age become infected at rates that exceed those of older children and adults by several-fold [<a href="#rid10">10-12</a>]. For unknown reasons, males have a risk of disease that exceeds the risk in females by as much as 50 percent.</p><p class="headingAnchor" id="H6"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Transmission of enteroviruses and parechoviruses occurs predominantly via direct or indirect oral contact with virus shed in the upper respiratory tract and feces. Transmission is enhanced by poor sanitary conditions and may occur via numerous routes, including contaminated water, food, and fomites. Epidemiologic and experimental observations suggest that the respiratory route is the principal mode of transmission for some serotypes, including coxsackievirus A21 and enterovirus D68 [<a href="#rid13">13,14</a>]. Enterovirus D70 is shed in tears and is readily spread via fingers and fomites [<a href="#rid15">15</a>].</p><p>Longitudinal studies demonstrate that secondary infections occur at high rates in susceptible household contacts [<a href="#rid16">16,17</a>]. Infants, particularly those in diapers, are efficient transmitters. The relative role of virus shedding by symptomatic and asymptomatic persons is not known, but it is likely that both are important.</p><p class="headingAnchor" id="H7"><span class="h2">Periodicity and variability of disease by serotype</span><span class="headingEndMark"> — </span>The contribution of individual enterovirus and parechovirus serotypes to human infection and disease varies substantially for reasons that are not fully known. Multi-year cycles with different periodicities are observed for many serotypes that follow rhythmic variation in population immunity whereby an accumulation of a "critical mass" of susceptible children may be necessary to exceed a population immunity threshold to sustain transmission [<a href="#rid18">18,19</a>].</p><p>A small number of serotypes cause endemic disease in patterns that vary regionally over short cycles. Other serotypes are responsible for widespread outbreaks in which the epidemic strain accounts for more than 30 percent of all isolated enteroviruses, followed by several years of relative quiescence [<a href="#rid20">20</a>]. During outbreaks, the number of reported enterovirus disease cases may increase many-fold over background rates of infection during intervening periods [<a href="#rid21">21</a>]. Occasional epidemics are nearly global, such as those caused by echovirus 9 in the late 1950s, the worldwide pandemic of acute hemorrhagic conjunctivitis due to enterovirus D70 that began in 1969, and the 1979 to 1980 echovirus 11 epidemic.</p><p>According to the most recent report of the National Enterovirus Surveillance System maintained at the Centers for Disease Control and Prevention (CDC), the most common serotypes reported in the United States in 2022 were enterovirus D68 and human parechovirus 3 [<a href="#rid22">22</a>].</p><p>Some enterovirus serotypes (eg, echovirus 1, coxsackievirus B6, and enterovirus B69) are rarely recognized clinically and to date have exhibited little epidemic potential.</p><p>Other previously obscure serotypes have recently emerged to cause widespread disease including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coxsackievirus A6</strong> is the cause of outbreaks of an atypical form of hand, foot, and mouth disease in infants and young children in multiple sites in Europe, the Far East, and North America [<a href="#rid23">23,24</a>]. (See  <a class="medical medical_review" href="/z/d/html/13739.html" rel="external">"Atypical exanthems in children", section on 'Atypical hand, foot, and mouth disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Enterovirus D68</strong> has been responsible for clusters of respiratory disease in the United States and other countries since 2008, and more recently in many states throughout the United States in the late summer/early autumn [<a href="#rid25">25,26</a>]. Rare cases of acute motor neuron disease similar to poliomyelitis (acute flaccid myelitis), attributed to enterovirus D68 and initially reported in California in 2012, occurred throughout the United States and other countries in the context of biennial surges of respiratory infections between 2014 and 2018 [<a href="#rid27">27-29</a>]. Clinical issues related to enterovirus D68 are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Respiratory disease'</a> and  <a class="medical medical_review" href="/z/d/html/126102.html" rel="external">"Acute flaccid myelitis"</a>.)</p><p></p><p>Enterovirus A71 has evolved as a unique cause of epidemic paralysis in localized outbreaks involving small numbers of patients [<a href="#rid30">30-33</a>] and in far larger regional epidemics in the Asia-Pacific region, affecting hundreds to thousands of persons in a single season [<a href="#rid34">34-38</a>]. Infants and young children are at risk of brain stem encephalitis associated with high mortality related to rapid cardiovascular collapse and pulmonary edema [<a href="#rid39">39-41</a>]. Effective vaccines have been developed and licensed in China but have not yet been applied broadly in public immunization programs [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Vaccines'</a>.)</p><p>Laboratory evidence of parechovirus infection is found in about 5 to 10 percent of specimens submitted for enterovirus testing [<a href="#rid43">43</a>]. The most common parechovirus serotypes are 1 and 3, with type 3 (PeV-A3) predominating as a cause of central nervous system infection [<a href="#rid43">43,44</a>]. In July 2022, the United States Centers for Disease Control and Prevention alerted clinicians to the circulation of PeV-A3 in multiple states. Since parechovirus laboratory testing has become more widely available, it is unclear if the identified cases are reflective of increased testing rather than an increased number of infections [<a href="#rid45">45,46</a>].</p><p class="headingAnchor" id="H9"><span class="h1">PATHOGENESIS</span></p><p class="headingAnchor" id="H11"><span class="h2">Viral replication and dissemination</span><span class="headingEndMark"> — </span>Knowledge of in vivo enterovirus replication and dissemination is largely based upon the studies of poliovirus infection in primates [<a href="#rid47">47,48</a>]. The initial sites of virus replication include both the pharynx and terminal ileum. Replication gives rise to a transient, "minor" viremia, which spreads virus hematogenously to lymphoid tissue throughout the body. Subsequent replication at these sites produces a "major" viremia, which coincides with the onset of symptoms, and results in spread of virus to target organs such as the skin, heart, and central nervous system.</p><p class="headingAnchor" id="H12"><span class="h2">Immune response</span><span class="headingEndMark"> — </span>Convention holds that immunity to enterovirus and parechovirus infection is serotype specific, in part because when reinfection with the same enterovirus serotype occurs, it is invariably asymptomatic. However, studies with monovalent poliovirus vaccines have clearly shown that primary infection may induce heterotypic immune responses [<a href="#rid49">49</a>].</p><p>Early studies in mice identified the importance of resident host macrophages in protection from disease [<a href="#rid50">50-52</a>]; experimental poliovirus and group B coxsackievirus infections have demonstrated the role of macrophage TLR-3 signaling and induction of innate interferon responses [<a href="#rid50">50-53</a>]. The humoral immune response plays a central role in response to infection and in prevention of reinfection through generation of antibody-producing plasma cells and memory B cells.</p><p>Circulating poliovirus type-specific IgA alpha4beta7-positive cells home to mucosal surfaces and precede the development of secretory IgA in mucosal secretions and colostrum approximately two weeks after infection [<a href="#rid54">54,55</a>].</p><p>Th1 helper T cells generated from transgenic mice bearing human poliovirus receptor (PVR), in particular, induce MHC Class II activity against poliovirus-infected cells in vitro and provide helper activity for humoral immune responses in vivo [<a href="#rid56">56</a>]. However, T lymphocytes do not necessarily contribute to viral clearance. To the contrary, in the murine model of coxsackievirus B3 myocarditis, the cytotoxic T cell response enhances myocardial inflammation and increases mortality [<a href="#rid57">57,58</a>].</p><p>Certain hosts are more susceptible to serious, life-threatening disease. Neonates may develop serious and sometimes fatal systemic enterovirus infections, which may be transmitted from infected mothers or acquired from other close contacts in the perinatal period. In addition, enteroviruses can cause persistent infections in patients with hereditary or acquired defects in B lymphocyte function, such as X-linked agammaglobulinemia or adults with common variable immunodeficiency. (See  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Immunocompromised patients'</a>.)</p><p class="headingAnchor" id="H179084871"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/83075.html" rel="external">"Patient education: Hand, foot, and mouth disease and herpangina (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/96986.html" rel="external">"Patient education: Enterovirus D68 (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H24150874"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification – </strong>The human enteroviruses include polioviruses, group A and B coxsackieviruses, echoviruses, and enteroviruses. Human parechoviruses are genetically related to enteroviruses (but are classified in a separate picornavirus genus) and together share many epidemiological and clinical characteristics. (See <a class="local">'Classification'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enteroviruses and parechoviruses are transmitted predominately via fecal-oral contact and cause infection throughout the year, although persons in temperate climates experience higher rates of infection in summer and fall. Infants less than one year of age become infected at rates that exceed those of older children and adults by several-fold. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The more common enterovirus serotypes include group B coxsackieviruses 1 to 5 and some echoviruses. A small number of serotypes cause endemic disease in patterns that vary regionally on an annual basis. Other serotypes (eg, echoviruses 9, 11, and 30, enterovirus D68) are responsible for widespread outbreaks followed by several years of relative quiescence. (See <a class="local">'Periodicity and variability of disease by serotype'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enterovirus A71 has caused widespread outbreaks in China, Taiwan, and Southeast Asia associated with serious central nervous system complications that are similar to poliomyelitis. Outbreaks of respiratory infections caused by enterovirus D68 in the United States and elsewhere have also included paralysis as a rare complication. (See <a class="local">'Periodicity and variability of disease by serotype'</a> above and  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Acute paralysis and brainstem encephalitis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Most parechovirus infections are caused by types 1 to 3. (See <a class="local">'Periodicity and variability of disease by serotype'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010; 9:1097.</a></li><li><a class="nounderline abstract_t">Murphy OC, Messacar K, Benson L, et al. Acute flaccid myelitis: cause, diagnosis, and management. Lancet 2021; 397:334.</a></li><li class="breakAll">Picornaviridae Study Group. Taxa. http://www.picornastudygroup.com/taxa/taxa.htm (Accessed on March 29, 2023).</li><li><a class="nounderline abstract_t">Melnick JL. The discovery of the enteroviruses and the classification of poliovirus among them. Biologicals 1993; 21:305.</a></li><li class="breakAll">Picornaviridae, King AMQ, Brown F, Christian P, et al (Eds), Academic Press, New York 2000.</li><li><a class="nounderline abstract_t">Oberste MS, Maher K, Kilpatrick DR, et al. Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 1999; 37:1288.</a></li><li><a class="nounderline abstract_t">Joki-Korpela P, Hyypiä T. Parechoviruses, a novel group of human picornaviruses. Ann Med 2001; 33:466.</a></li><li class="breakAll">Rueckert RR. Picornaviridae and their replication. In: Virology, 2nd Ed, Fields BN, Knipe DM (Eds), Raven Press, New York 1990. p.507.</li><li><a class="nounderline abstract_t">Moore M. Centers for Disease Control. Enteroviral disease in the United States, 1970-1979. J Infect Dis 1982; 146:103.</a></li><li><a class="nounderline abstract_t">GELFAND HM, HOLGUIN AH, MARCHETTI GE, FEORINO PM. A CONTINUING SURVEILLANCE OF ENTEROVIRUS INFECTIONS IN HEALTHY CHILDREN IN SIX UNITED STATES CITIES. I. VIRUSES ISOLATED DURING 1960 AND 1961. Am J Hyg 1963; 78:358.</a></li><li><a class="nounderline abstract_t">Marier R, Rodriguez W, Chloupek RJ, et al. Coxsackievirus B5 infection and aseptic meningitis in neonates and children. Am J Dis Child 1975; 129:321.</a></li><li><a class="nounderline abstract_t">Wilfert CM, Lauer BA, Cohen M, et al. An epidemic of echovirus 18 meningitis. J Infect Dis 1975; 131:75.</a></li><li><a class="nounderline abstract_t">Couch RB, Douglas RG Jr, Lindgren KM, et al. Airborne transmission of respiratory infection with coxsackievirus A type 21. Am J Epidemiol 1970; 91:78.</a></li><li><a class="nounderline abstract_t">Midgley CM, Watson JT, Nix WA, et al. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 2015; 3:879.</a></li><li><a class="nounderline abstract_t">Onorato IM, Morens DM, Schonberger LB, et al. Acute hemorrhagic conjunctivitis caused by enterovirus type 70: an epidemic in American Samoa. Am J Trop Med Hyg 1985; 34:984.</a></li><li><a class="nounderline abstract_t">Kogon A, Spigland I, Frothingham TE, et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol 1969; 89:51.</a></li><li><a class="nounderline abstract_t">Chang LY, Tsao KC, Hsia SH, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 2004; 291:222.</a></li><li><a class="nounderline abstract_t">Gondo K, Kusuhara K, Take H, Ueda K. Echovirus type 9 epidemic in Kagoshima, southern Japan: seroepidemiology and clinical observation of aseptic meningitis. Pediatr Infect Dis J 1995; 14:787.</a></li><li><a class="nounderline abstract_t">Pons-Salort M, Grassly NC. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science 2018; 361:800.</a></li><li><a class="nounderline abstract_t">Khetsuriani N, Lamonte-Fowlkes A, Oberst S, et al. Enterovirus surveillance--United States, 1970-2005. MMWR Surveill Summ 2006; 55:1.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control (CDC). Aseptic meningitis--New York State and United States, weeks 1-36, 1991. MMWR Morb Mortal Wkly Rep 1991; 40:773.</a></li><li class="breakAll">Centers for Disease Control and Prevention. National Enterovirus Surveillance System (NESS). Surveillance Data: 2022. https://www.cdc.gov/surveillance/ness/surv-data.html#summary-2022 (Accessed on October 16, 2023).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 - Alabama, Connecticut, California, and Nevada, November 2011-February 2012. MMWR Morb Mortal Wkly Rep 2012; 61:213.</a></li><li><a class="nounderline abstract_t">Mathes EF, Oza V, Frieden IJ, et al. "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics 2013; 132:e149.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Clusters of acute respiratory illness associated with human enterovirus 68--Asia, Europe, and United States, 2008-2010. MMWR Morb Mortal Wkly Rep 2011; 60:1301.</a></li><li><a class="nounderline abstract_t">Midgley CM, Jackson MA, Selvarangan R, et al. Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:798.</a></li><li><a class="nounderline abstract_t">Kreuter JD, Barnes A, McCarthy JE, et al. A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med 2011; 135:793.</a></li><li><a class="nounderline abstract_t">Pastula DM, Aliabadi N, Haynes AK, et al. Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014. MMWR Morb Mortal Wkly Rep 2014; 63:901.</a></li><li><a class="nounderline abstract_t">Ayscue P, Van Haren K, Sheriff H, et al. Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. MMWR Morb Mortal Wkly Rep 2014; 63:903.</a></li><li><a class="nounderline abstract_t">Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974; 129:304.</a></li><li><a class="nounderline abstract_t">Chonmaitree T, Menegus MA, Schervish-Swierkosz EM, Schwalenstocker E. Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics 1981; 67:489.</a></li><li><a class="nounderline abstract_t">Samuda GM, Chang WK, Yeung CY, Tang PS. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J 1987; 6:206.</a></li><li><a class="nounderline abstract_t">Kennett ML, Birch CJ, Lewis FA, et al. Enterovirus type 71 infection in Melbourne. Bull World Health Organ 1974; 51:609.</a></li><li><a class="nounderline abstract_t">Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999; 341:929.</a></li><li><a class="nounderline abstract_t">Gilbert GL, Dickson KE, Waters MJ, et al. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J 1988; 7:484.</a></li><li><a class="nounderline abstract_t">Shindarov LM, Chumakov MP, Voroshilova MK, et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol 1979; 23:284.</a></li><li><a class="nounderline abstract_t">Nagy G, Takátsy S, Kukán E, et al. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol 1982; 71:217.</a></li><li><a class="nounderline abstract_t">Miwa C, Ohtani M, Watanabe H, et al. Epidemic of hand, foot and mouth disease in Gifu Prefecture in 1978. Jpn J Med Sci Biol 1980; 33:167.</a></li><li><a class="nounderline abstract_t">Lum LC, Wong KT, Lam SK, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998; 133:795.</a></li><li><a class="nounderline abstract_t">Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999; 341:936.</a></li><li><a class="nounderline abstract_t">Chan KP, Goh KT, Chong CY, et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 2003; 9:78.</a></li><li><a class="nounderline abstract_t">Chong P, Liu CC, Chow YH, et al. Review of enterovirus 71 vaccines. Clin Infect Dis 2015; 60:797.</a></li><li><a class="nounderline abstract_t">Romero JR, Selvarangan R. The human Parechoviruses: an overview. Adv Pediatr 2011; 58:65.</a></li><li><a class="nounderline abstract_t">Harvala H, McLeish N, Kondracka J, et al. Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol 2011; 83:889.</a></li><li class="breakAll">CDC Health Alert Network Health Advisory. Recent Reports of Human Parechovirus (PeV) in the United States - 2022. United States Centers for Disease Control and Prevention. July 12, 2022. https://emergency.cdc.gov/han/2022/han00469.asp (Accessed on March 29, 2023).</li><li><a class="nounderline abstract_t">Tao L, Fill MA, Banerjee R, Humphries RM. Notes from the Field: Cluster of Parechovirus Central Nervous System Infections in Young Infants - Tennessee, 2022. MMWR Morb Mortal Wkly Rep 2022; 71:977.</a></li><li><a class="nounderline abstract_t">HORSTMANN DM. Clinical aspects of acute poliomyelitis. Am J Med 1949; 6:592.</a></li><li><a class="nounderline abstract_t">Shen L, Chen CY, Huang D, et al. Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis. J Virol 2017; 91.</a></li><li><a class="nounderline abstract_t">ASHKENAZI A, MELNICK JL. Heterotypic antibody response after feeding of monovalent attenuated live poliovaccine. N Engl J Med 1962; 267:1228.</a></li><li><a class="nounderline abstract_t">Rager-Zisman B, Allison AC. The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol 1973; 19:329.</a></li><li><a class="nounderline abstract_t">Abe Y, Fujii K, Nagata N, et al. The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J Virol 2012; 86:185.</a></li><li><a class="nounderline abstract_t">Ida-Hosonuma M, Iwasaki T, Yoshikawa T, et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 2005; 79:4460.</a></li><li><a class="nounderline abstract_t">Richer MJ, Lavallée DJ, Shanina I, Horwitz MS. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 2009; 4:e4127.</a></li><li><a class="nounderline abstract_t">Ogra PL, Karzon DT. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol 1969; 102:1423.</a></li><li><a class="nounderline abstract_t">Dey A, Molodecky NA, Verma H, et al. Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus. PLoS One 2016; 11:e0146010.</a></li><li><a class="nounderline abstract_t">Mahon BP, Katrak K, Nomoto A, et al. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med 1995; 181:1285.</a></li><li><a class="nounderline abstract_t">Rose NR, Wolfgram LJ, Herskowitz A, Beisel KW. Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis. Ann N Y Acad Sci 1986; 475:146.</a></li><li><a class="nounderline abstract_t">Woodruff JF. Viral myocarditis. A review. Am J Pathol 1980; 101:425.</a></li></ol></div><div id="topicVersionRevision">Topic 2694 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20965438" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical features, diagnosis, and management of enterovirus 71.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33357469" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Acute flaccid myelitis: cause, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33357469" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Acute flaccid myelitis: cause, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8024744" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The discovery of the enteroviruses and the classification of poliovirus among them.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8024744" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The discovery of the enteroviruses and the classification of poliovirus among them.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10203472" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Typing of human enteroviruses by partial sequencing of VP1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11680794" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Parechoviruses, a novel group of human picornaviruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11680794" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Parechoviruses, a novel group of human picornaviruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6282988" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Centers for Disease Control. Enteroviral disease in the United States, 1970-1979.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14071359" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A CONTINUING SURVEILLANCE OF ENTEROVIRUS INFECTIONS IN HEALTHY CHILDREN IN SIX UNITED STATES CITIES. I. VIRUSES ISOLATED DURING 1960 AND 1961.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1121962" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Coxsackievirus B5 infection and aseptic meningitis in neonates and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1167369" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : An epidemic of echovirus 18 meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5415578" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Airborne transmission of respiratory infection with coxsackievirus A type 21.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26482320" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2994502" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Acute hemorrhagic conjunctivitis caused by enterovirus type 70: an epidemic in American Samoa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5762818" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14722149" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8559629" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Echovirus type 9 epidemic in Kagoshima, southern Japan: seroepidemiology and clinical observation of aseptic meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30139872" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16971890" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Enterovirus surveillance--United States, 1970-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1944124" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Aseptic meningitis--New York State and United States, weeks 1-36, 1991.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1944124" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Aseptic meningitis--New York State and United States, weeks 1-36, 1991.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22456122" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 - Alabama, Connecticut, California, and Nevada, November 2011-February 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23776120" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21956405" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Clusters of acute respiratory illness associated with human enterovirus 68--Asia, Europe, and United States, 2008-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25211545" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21631275" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A fatal central nervous system enterovirus 68 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25299607" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25299608" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4361245" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : An apparently new enterovirus isolated from patients with disease of the central nervous system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7254970" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3562141" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4377551" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Enterovirus type 71 infection in Melbourne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10498487" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2841639" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/231067" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6285858" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6259389" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Epidemic of hand, foot and mouth disease in Gifu Prefecture in 1978.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9842048" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Fatal enterovirus 71 encephalomyelitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10498488" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Neurologic complications in children with enterovirus 71 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12533285" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25352588" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Review of enterovirus 71 vaccines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21736976" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The human Parechoviruses: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21412796" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21412796" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35900934" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Notes from the Field: Cluster of Parechovirus Central Nervous System Infections in Young Infants - Tennessee, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18126001" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Clinical aspects of acute poliomyelitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28356537" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13965178" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Heterotypic antibody response after feeding of monovalent attenuated live poliovaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4353212" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22072781" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15767446" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19122812" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4977607" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26730586" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7699320" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3024549" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6254364" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Viral myocarditis. A review.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
